Clinical Trial Update: Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease [Phase 3]

View source ↗

Summary

Phase III clinical trial evaluating lifitegrast ophthalmic solution for dry eye disease is currently recruiting; sponsored by Lunan Better Pharmaceutical Co., L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Lifitegrast ophthalmic solution (lifitegrast)

Snippet

Sponsor: Lunan Better Pharmaceutical Co., LTD. | Conditions: Dry Eye Disease (DED) | Phase 3 | Status: RECRUITING